Q3 revenue below expectations for Dr Martens
Dr Martens has reported its financial results for the third quarter of the current financial year, with lower-than-expected revenue.
Read More...
PRINT & DIGITAL
Dr Martens reports growth for first half results
Dr Martens has reported its interim results for the six months to September 30, 2022, with revenue up by 13% to £418.6 million (US$506.41 million).
Read More...
Dr Martens launches resale scheme
British footwear brand Dr Martens has partnered with second-hand marketplace Depop to launch a new resale scheme.
Read More...
Revenue jumps 16% for Dr Martens in H1
The footwear brand has reported its financial results for the first half of the 2022 financial year, with revenue increasing by 16% to £369.9 million (US$489 million).
Read More...
Dr Martens considers initial public offering
The iconic British footwear brand announced it is considering an initial public offering (IPO) and is set to apply for admission of its ordinary shares to the premium listing segment of the Official List of the FCA and trade on the main market of the London Stock Exchange.
Read More...Permira could resume talks on Dr Martens sale
Dr Martens could reportedly exit Permira Funds through an IPO.
Read More...
Significant annual growth for Dr Martens
The iconic British footwear brand has posted revenue up 48% to £672.2 million (US$877.3 million) for the year ending March 31, 2020.
Read More...
New owner for Golden Goose
The Italian high-end sneaker brand has been sold to Permira Holdings, which owns the iconic British footwear label Dr Martens.
Read More...
Dr Martens could change hands
Permira Funds, owners of the iconic British footwear brand, are reported to have brought on advisors to help explore the possibility of a sale or IPO of Dr Martens in 2020.
Read More...
Dr Martens posts strong annual growth
The iconic British footwear manufacturer has delivered 30% revenue and 70% EBITDA growth for the year ended March 31, 2019.
Read More...
